Medtronic announces a Chief Medical Officer from Cleveland Medical Center

October 31, 2024  Source: drugdu 35

"/On October 28, 2024, Medtronic announced the appointment of Dr. Matthew Kroh as Chief Medical Officer for Advanced and General Surgery Technologies. Dr. Matthew Crowe is the Vice President of Innovation and Technology at the Cleveland Clinic Digestive Disease and Surgery Institute. He is the director of the Department of General Surgery, Endoscopic Surgery, and Foreintestinal Surgery.

01. Surgical Laparoscopic Specialist at Cleveland Medical Center
Cleveland Clinic is one of the world's most renowned medical institutions, founded on February 28, 1921. In the 2017-2018 ranking of the best hospitals in the United States, Cleveland Clinic ranked second overall, only behind Mayo Clinic. Among them, cardiac surgery and urology are ranked first in the United States; General surgery, rheumatology, and nephrology rank second. Dr. Matthew Crowe is from Cleveland Medical Center.

According to the official website of the Cleveland Clinic, Dr. Matthew Crowe is the Vice President of Innovation and Technology at the Cleveland Clinic Institute of Digestive Diseases and Surgery. He is the director of the Department of General Surgery, Endoscopic Surgery, and Foreintestinal Surgery. Dr. Cro also works at the Obesity and Metabolism Institute and the Surgical Innovation, Technology, and Education Center located on the main campus of the Cleveland Clinic. He is a professor of surgery at the Lerner School of Medicine at the Cleveland Clinic. He has obtained a license from the Ohio State Medical Board and certification from the American Surgical Board. His expertise includes advanced laparoscopic surgery, weight loss surgery, gastrointestinal surgery, surgical endoscopy, single incision laparoscopic surgery, and robotic surgery.

After obtaining a Bachelor's degree in Biology from Boston College and a Master's degree from Boston University, Dr. Cro earned a medical degree from Mount Sinai School of Medicine at New York University.

Dr. Cro has given extensive speeches on laparoscopic and weight loss surgery and related topics at medical conferences nationwide and around the world. He has also collaborated with others to write numerous articles and book chapters, which have appeared in leading medical journals such as the Journal of the American Society of Surgeons and Endoscopy. He has participated in numerous research projects in this field, including fluorescence microscopy as an auxiliary tool for laparoscopic gastric band adjustment in morbidly obese patients, predictive factors for advanced liver disease in patients undergoing weight loss surgery, development of new Barrett's esophagoscope management equipment, and new methods for minimally invasive laparoscopic surgery, including robotics technology, single incision laparoscopic surgery, NOTES surgery, POEM, and ESD surgery.

He is a member of associations such as the American College of Surgeons, the American Society of Surgeons, the American Society of Metabolic and Obesity Surgery, the American Society of Gastrointestinal and Endoscopic Surgeons, the Association of Surgical Educators, the American Society of Gastrointestinal Endoscopists, and the Central Surgical Association.

Kro is a professionally certified surgeon with extensive experience in advanced laparoscopic and weight loss surgeries, as well as surgical endoscopes. On the official website of Cleveland Clinic, 108 patients gave him an average rating of 4.8. Many patients agree that he is an excellent doctor.

In his new position, Cro plans to continue working in surgery at the Cleveland Clinic.

I am honored to join Medtronic, a company known for innovation leading healthcare change, "said Kroos." I look forward to contributing to the development of surgical techniques that can enable more patients worldwide to receive treatment and improve their outcomes.

Regarding the addition of Kroos, Medtronic stated that he has extensive clinical and healthcare leadership experience and can guide the development and commercialization strategies of new products. Medtronic stated that under his leadership, the company aims to deepen clinical insights and strengthen collaboration with doctors and medical communities. Kroos' appointment demonstrates the company's commitment to promoting surgical innovation and improving patient treatment outcomes.

We are delighted that Dr. Cro has joined Medtronic, adding his expertise, passion, and innovative spirit to our business, "said Justin Roberts, General Manager and Vice President of Advanced Surgical Technologies at Medtronic's Surgical Business Unit." His pioneering experience in surgical innovation will be invaluable to us as we continue to push the boundaries of medical technology.

02. Medtronic Surgeons Hires Expert as Chief Medical Officer
The change in executives indicates that Medtronic's layout in surgery is gradually increasing.

In September of this year, Medtronic officially appointed Dr. James Porter, a urology specialist, as the Chief Medical Officer (CMO) for Robotics and Digital Technology in the surgical business. Dr. Porter has extensive experience in over 5000 robot assisted surgeries in the field of urology and is recognized as a "recognized leader" in the global surgical field. In addition, he is also one of the top robotic surgery experts in the United States, ranking among the top five in the country. Dr. Porter previously worked at Harbour View Medical Center as the Director of Urology, and later served as the Head of Laparoscopic and Robotic Surgery at the Department of Urology at the University of Washington Medical Center.

This business is part of the medical surgical product portfolio - on February 1, 2023, Medtronic announced the merger of its surgical robotics and surgical innovation business units into one surgical business unit. The main core of the new business unit is Medtronic's robot assisted surgery system Hugo.

Medtronic stated that Dr. Porter's joining brings rich clinical experience to the company, which can help further enhance its robotics and digital technology business. His responsibilities include managing the strategic direction of clinical evidence programs and collaborating closely with doctors and various sectors of society. At the same time, he will continue to perform surgeries part-time at Providence Swedish Hospital in Seattle.

Regarding this appointment, Porter said, "My original intention in medicine was to help patients, and I am very excited to be able to expand this influence globally through Medtronic. There are still millions of patients worldwide who cannot receive minimally invasive surgical treatment, and I look forward to working with the Medtronic team to promote the development of medical technology.

Source: http://qixieke.com/Font/index/detailPage.html?id=3235-19

By editor
Share: 

your submission has already been received.

OK

Subscribe

Please enter a valid Email address!

Submit

The most relevant industry news & insight will be sent to you every two weeks.